29 results for «131»

Filter By

29 results

Complex non left main bifurcation - LIVE Case

11 Oct 2025 – From AICT-AsiaPCR 2025

A 55-year-old male with no risk factors presented with an anterior STEMI treated by primary PCI of the LAD. Coronary angiography revealed triple-vessel disease. The RCA was treated one month later with a DCB, and the bifurcation LCX/OM (Medina 1,1,1) was treated during the live procedure....

Complex non left main bifurcation - LIVE Case

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

STOPDAPT-2 ACS: exploring the limits of short DAPT

31 Aug 2021

Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.

Dejan Milasinovic

Author

Dejan Milasinovic
ESC Congress 2021 - STOPDAPT-2 ACS: exploring the limits of short DAPT

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure

03 Feb 2022

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease

02 Sep 2025

Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTION STEMI - Immediate vs staged complete revascularisation during index admission in patients with STEMI & MVD

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?